Therefore, we evaluated the influence of EGFR expression on GBM cell survival by comparing the survival rate of EGFR+ (EGFRvIII overexpressing U87MG cells) and EGFR− (EGFvIII mock U87MG cells) after TMZ treatment. This evidence concerns the gene EGFR and glioblastoma.